E-LIB Suche - Ergebnisse für: Manolis, Efthymios

1

EMA perspective on the value of model‐informed drug develop..:

Manolis, Efthymios ; Musuamba, Flora Tshinanu ; de Vries, Corinne S...
CPT: Pharmacometrics & Systems Pharmacology. , 2024

Link: https://doi.org/10.1002/..

2

Using mechanistic models to support development of complex ..:

Manolis, Efthymios ; García‐Arieta, Alfredo ; Lindahl, Anders...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 5 - p. 556-559 , 2023

Link: https://doi.org/10.1002/..

3

Model‐Informed Drug Development: Steps Toward Harmonized Gu..:

Marshall, Scott ; Ahamadi, Malidi ; Chien, Jenny...
Clinical Pharmacology & Therapeutics. 114 (2023) 5 - p. 954-959 , 2023

Link: https://doi.org/10.1002/..

4

Drug Clearance in Neonates: A Combination of Population Pha..:

Tang, Bo-Hao ; Guan, Zheng ; Allegaert, Karel...
Clinical Pharmacokinetics. 60 (2021) 11 - p. 1435-1448 , 2021

Link: https://doi.org/10.1007/..

5

The European Medicines Agency Experience With Pediatric Dos..:

Manolis, Efthymios ; Musuamba, Flora T. ; Karlsson, Kristin E.
The Journal of Clinical Pharmacology. 61 (2021) S1 - p. , 2021

Link: https://doi.org/10.1002/..

6

Scientific and regulatory evaluation of mechanistic in sili..:

Musuamba, Flora T. ; Skottheim Rusten, Ine ; Lesage, Raphaëlle...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 8 - p. 804-825 , 2021

Link: https://doi.org/10.1002/..

7

Regulatory Considerations for Building an In Silico Clinica..:

Manolis, Efthymios ; Musuamba, Flora T. ; Karlsson, Kristin E.
Clinical Pharmacology & Therapeutics. 107 (2020) 4 - p. 746-748 , 2020

Link: https://doi.org/10.1002/..

8

Verifying and Validating Quantitative Systems Pharmacology ..:

Musuamba, Flora T. ; Bursi, Roberta ; Manolis, Efthymios...
CPT: Pharmacometrics & Systems Pharmacology. 9 (2020) 4 - p. 195-197 , 2020

Link: https://doi.org/10.1002/..

9

Model‐Informed Drug Discovery and Development: Current Indu..:

Marshall, Scott ; Madabushi, Rajanikanth ; Manolis, Efthymios...
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 2 - p. 87-96 , 2019

Link: https://doi.org/10.1002/..

10

Critical Path for Parkinson's: Catalyzing Innovation for Pa..:

Stephenson, Diane ; Akalu, Mussie ; Alexander, Robert...
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

11

Commentary on the EMA Reflection Paper on the use of extrap..:

Ollivier, Cécile ; Thomson, Andrew ; Manolis, Efthymios...
British Journal of Clinical Pharmacology. 85 (2019) 4 - p. 659-668 , 2019

Link: https://doi.org/10.1111/..

12

Commentary on the MID3 Good Practices Paper:

Manolis, Efthymios ; Brogren, Jacob ; Cole, Susan...
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 7 - p. 416-417 , 2017

Link: https://doi.org/10.1002/..

13

Chest imaging in CF studies - Commentary:

Eichler, Irmgard ; Manolis, Efthymios
Journal of Cystic Fibrosis. 16 (2017) 2 - p. 173-174 , 2017

Link: https://doi.org/10.1016/..

14

Hollow Fiber System Model for Tuberculosis: The European Me..:

Cavaleri, Marco ; Manolis, Efthymios
Clinical Infectious Diseases. 61 (2015) - p. S1-S4 , 2015

Link: https://www.jstor.org/st..

15

Hollow Fiber System Model for Tuberculosis: The European Me..:

Cavaleri, Marco ; Manolis, Efthymios
Clinical Infectious Diseases. 61 (2015) suppl 1 - p. S1-S4 , 2015

Link: https://doi.org/10.1093/..